Literature DB >> 16491388

Conservative use of chest-tube insertion in children with pleural effusion.

R Epaud1, G Aubertin, M Larroquet, H Ducou-le Pointe, P Helardot, A Clement, B Fauroux.   

Abstract

The aim of this work was to evaluate the effect of a more conservative use of chest-tube insertion on the short-term and long-term outcome of pleural infection. Sixty-five patients with pleural infection, aged 1 month to 16 years were each treated according to one of the two protocols: classical management with chest-tube insertion (classical group, n = 33), or conservative use of chest-tube insertion (conservative group, n = 32), with drainage indicated only in the case of voluminous pleural effusion defined by a mediastinal shift and respiratory distress and/or an uncontrolled septic situation. The two groups were comparable with regard to age, baseline C-reactive protein (CRP) value and white blood cell counts, pleural thickness, identified bacteria, and antibiotic treatment. Chest-tube insertion was performed in 17 patients (52%) of the classical group compared to eight patients (25%) of the conservative group (P = 0.03). Duration of temperature above 39 degrees C was shorter in the conservative group (10 +/- 1 vs. 14 +/- 1 days, P = 0.01), as was the normalization of CRP (13 +/- 1 vs. 17 +/- 1 days, P = 0.03). Duration of hospitalization and intravenous (IV) antibiotherapy as well as the delay of chest-radiograph normalization was not significantly different between the two groups. A more conservative use of chest-tube insertion did not change short- and long-term outcome of the pleural infection in children. Drainage could be restricted to the most severely affected patients with pleural empyema causing a mediastinal shift and respiratory distress and/or presenting with an uncontrolled septic situation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491388     DOI: 10.1007/s00383-006-1645-4

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  24 in total

1.  Complication rates of tube thoracostomy.

Authors:  L Chan; K M Reilly; C Henderson; F Kahn; R F Salluzzo
Journal:  Am J Emerg Med       Date:  1997-07       Impact factor: 2.469

2.  A randomized trial of empyema therapy.

Authors:  M A Wait; S Sharma; J Hohn; A Dal Nogare
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

3.  An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.

Authors:  Carrie L Byington; LaShonda Y Spencer; Timothy A Johnson; Andrew T Pavia; Daniel Allen; Edward O Mason; Sheldon Kaplan; Karen C Carroll; Judy A Daly; John C Christenson; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2002-01-03       Impact factor: 9.079

4.  Urokinase in the management of complicated parapneumonic effusions in children.

Authors:  S Krishnan; N Amin; A J Dozor; G Stringel
Journal:  Chest       Date:  1997-12       Impact factor: 9.410

5.  Postpneumonic empyema in children treated by early decortication.

Authors:  R Rizalar; S Somuncu; F Bernay; E Aritürk; M Günaydin; N Gürses
Journal:  Eur J Pediatr Surg       Date:  1997-06       Impact factor: 2.191

6.  Randomised trial of intrapleural urokinase in the treatment of childhood empyema.

Authors:  A H Thomson; J Hull; M R Kumar; C Wallis; I M Balfour Lynn
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

7.  Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001.

Authors:  Steven C Buckingham; Michaela D King; Martha L Miller
Journal:  Pediatr Infect Dis J       Date:  2003-06       Impact factor: 2.129

8.  Postpneumonic empyema in childhood: selecting appropriate therapy.

Authors:  S J Hoff; W W Neblett; R M Heller; J B Pietsch; G W Holcomb; J R Sheller; T W Harmon
Journal:  J Pediatr Surg       Date:  1989-07       Impact factor: 2.545

9.  Clinical features, aetiology and outcome of empyema in children in the north east of England.

Authors:  K M Eastham; R Freeman; A M Kearns; G Eltringham; J Clark; J Leeming; D A Spencer
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

10.  Intrapleural streptokinase as adjunctive treatment for persistent empyema in pediatric patients.

Authors:  H Rosen; V Nadkarni; M Theroux; R Padman; J Klein
Journal:  Chest       Date:  1993-04       Impact factor: 9.410

View more
  1 in total

Review 1.  Clinical practice: treatment of childhood empyema.

Authors:  Marijke Proesmans; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.